logo

INAB

In8bio·NASDAQ
--
--(--)
--
--(--)

INAB fundamentals

In8bio (INAB) released its earnings on Aug 7, 2025: revenue was 0 (YoY --), met estimates; EPS was -1.24 (YoY +78.25%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-1.24
+78.25%
Report date
Aug 7, 2025
EPS
Q2,undefined
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-7.5-13.2-9.9-11.4-10.2-9.6-9-8.1-6.9-6.6-6-5.7-4.5-2.4-2.1-1.24
Forecast
-8.25-7.95-9.9-8.7-8.8-9.5-9.6-8.1-7.35-4.6-5.04-5.2-5.1-2.15-2.025-1.725
Surprise
0.00%
+9.09%
-66.04%
0.00%
-31.03%
-15.91%
-1.05%
+6.25%
0.00%
+6.12%
-43.48%
-19.05%
-9.62%
+11.76%
-11.63%
-3.70%
+28.12%
Revenue
Q2,undefined
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
--0000000000000000
Forecast
--0000000000000000
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Earnings Call